152 related articles for article (PubMed ID: 11923217)
1. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells.
Cellai C; Laurenzana A; Vannucchi AM; Della Malva N; Bianchi L; Paoletti F
FASEB J; 2002 May; 16(7):733-5. PubMed ID: 11923217
[TBL] [Abstract][Full Text] [Related]
2. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Dive C; Watson JV; Workman P
Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
[TBL] [Abstract][Full Text] [Related]
4. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
5. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells.
Paoletti F; Vannucchi AM; Mocali A; Caporale R; Burstein SA
Blood; 1995 Oct; 86(7):2624-31. PubMed ID: 7670106
[TBL] [Abstract][Full Text] [Related]
6. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
8. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
[TBL] [Abstract][Full Text] [Related]
10. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.
Bussolati B; Biancone L; Cassoni P; Russo S; Rola-Pleszczynski M; Montrucchio G; Camussi G
Am J Pathol; 2000 Nov; 157(5):1713-25. PubMed ID: 11073830
[TBL] [Abstract][Full Text] [Related]
11. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes.
Shimada A; Ota Y; Sugiyama Y; Sato S; Kume K; Shimizu T; Inoue S
J Invest Dermatol; 1998 Jun; 110(6):889-93. PubMed ID: 9620295
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
13. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
14. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Chen ZX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
[TBL] [Abstract][Full Text] [Related]
15. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
16. Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells.
Paoletti F; Mocali A
Cancer Res; 1988 Dec; 48(23):6674-7. PubMed ID: 3180077
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells.
Mallia CM; Aguirre V; McGary E; Tang Y; Scandurro AB; Liu C; Noguchi CT; Beckman BS
Exp Cell Res; 1999 Feb; 246(2):348-54. PubMed ID: 9925750
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
